论文部分内容阅读
以本院的96例2型糖尿病患者为例,使用随机的方法将96例患者分为对照组和观察组,每组各48例,对照组患者选择格列喹酮治疗,观察组患者选择格列美脲治疗,比较治疗后两组患者的治疗有效率、血糖指标的水平变化,用药期间随访3个月,对比两组患者的低血糖及并发症发生率。结果:观察组的治疗有效率高于对照组,并发症发生率及低血糖发生率低于对照组,P<0.05,用药后两组的空腹血糖、餐后2h血糖及糖化血红蛋白水平均优于治疗前,而观察组的改善结果优于对照组,P<0.05。结论:应用格列美脲治疗2型糖尿病的效果显著,能够更好的改善患者的血糖水平,应在临床进行推广。
Taking 96 patients with type 2 diabetes mellitus in our hospital as an example, 96 patients were randomly divided into control group and observation group, with 48 patients in each group. Patients in control group were treated with gliquidone, while those in observation group were selected After treatment, the treatment efficacies and the changes of blood glucose level were compared between the two groups after treatment. The patients were followed up for 3 months to compare the incidence of hypoglycemia and complications in both groups. Results: The effective rate of observation group was higher than that of control group, the complication rate and incidence of hypoglycemia were lower than those of control group (P <0.05). Fasting blood glucose, 2h postprandial blood glucose and glycosylated hemoglobin Before treatment, the observation group improved better than the control group, P <0.05. Conclusion: The application of glimepiride in the treatment of type 2 diabetes has a significant effect, which can better improve the blood sugar level in patients and should be promoted clinically.